Genzyme
Sanofi Genzyme, PerkinElmer Launch Free Dx Program for Patients With Lysosomal Storage Disorders
The Lantern Project will screen for patients who may be suffering from Gaucher disease, Fabry disease, Pompe disease, MPS I, or ASMD, and offer confirmatory DNA testing.
Veracyte Expands Afirma Co-promotion Deal with Genzyme to Brazil, Singapore
The firm also disclosed that it has paid $1.2 million in severance and bonuses related to its acquisition of Allegro Diagnostics.
The deal does not cover Voyager's fledgling effort to use RNAi to treat amyotrophic lateral sclerosis.
LabCorp Subsidiary Esoterix Sues Qiagen for Violation of EGFR Testing Licensing Terms
NEW YORK (GenomeWeb) – LabCorp subsidiary Esoterix Genetic Laboratories is suing Qiagen in a US district court alleging that Qiagen breached a licensing agreement between the companies regarding EGFR genetic testing by offering it for commercial research and diagnostic purposes ahead of US Food a
NEW YORK (GenomeWeb) – Researchers from Genzyme this month reported new proof-of-concept data showing that an expressed RNAi approach could be used to both prevent and treat the manifestations of Huntington's disease (HD) in an animal model of the condition.
Mar 27, 2014
Jan 16, 2014
Dec 5, 2013
Oct 25, 2012
Oct 25, 2012
Jan 20, 2012
Veracyte, Genzyme Co-marketing Thyroid Dx Tool
Jul 28, 2011
Apr 21, 2011
LabCorp Cutting 169 Jobs from Genzyme Genetics Unit
Feb 22, 2011
Paired Ends: Feb 22, 2011
Premium
Dec 1, 2010
LabCorp Completes Genzyme Genetics Buy
Nov 18, 2010
LabCorp Buy of Genzyme Genetics Clears FTC
Nov 16, 2010
LabCorp Offers $925M in Senior Notes
Sep 22, 2010
Sep 13, 2010